LAVA Therapeutics NV financial data

Symbol
LVTX on Nasdaq
Location
Yalelaan 62, Utrecht, Netherlands
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.3M shares
Common Stock, Shares, Outstanding 26.3M shares
Common Stock, Value, Issued 3.72M USD
Weighted Average Number of Shares Outstanding, Basic 26.9M shares +0.29%
Weighted Average Number of Shares Outstanding, Diluted 26.9M shares +0.29%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.74M USD -20.5%
General and Administrative Expense 2.55M USD -25.8%
Costs and Expenses 7.29M USD -22.4%
Operating Income (Loss) -7.29M USD +22.4%
Nonoperating Income (Expense) -1.28M USD -208%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.57M USD -4.3%
Income Tax Expense (Benefit) 72K USD -16.3%
Net Income (Loss) Attributable to Parent -8.64M USD -4.08%
Earnings Per Share, Basic -0.32 USD/shares -3.23%
Earnings Per Share, Diluted -0.32 USD/shares -3.23%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.4M USD
Other Assets, Current 2.4M USD
Assets, Current 60.5M USD
Property, Plant and Equipment, Net 43K USD
Other Assets, Noncurrent 9K USD
Assets 60.5M USD
Accounts Payable, Current 1.43M USD
Employee-related Liabilities, Current 1.21M USD
Liabilities, Current 5.61M USD
Contract with Customer, Liability, Noncurrent 35M USD
Liabilities 40.6M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -9.33M USD
Retained Earnings (Accumulated Deficit) -187M USD
Stockholders' Equity Attributable to Parent 19.9M USD -53.6%
Liabilities and Equity 60.5M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 90M shares +100%
Common Stock, Shares, Issued 26.3M shares
Common Stock, Par or Stated Value Per Share 0.14 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26.4M USD -24.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.29M USD +27.9%
Additional Paid in Capital 213M USD